InvestorsHub Logo
Followers 0
Posts 474
Boards Moderated 0
Alias Born 02/20/2023

Re: iclight post# 574318

Wednesday, 03/08/2023 10:43:08 AM

Wednesday, March 08, 2023 10:43:08 AM

Post# of 713469
yep- oncologists have learned a lot about psuedoprogression, the limits of PFS predictive power, etc since then. Much like you I'm just glad that the OS benefit is stellar and that patients are living longer in multiple trials with DCVAX-L, despite the inadequacy of PFS as an endpoint-. :)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News